ReShape Lifesciences Stock Scheduled to Reverse Split on Monday, August 18th (NASDAQ:RSLS)

Shares of ReShape Lifesciences Inc. (NASDAQ:RSLS) are scheduled to reverse split before the market opens on Monday, August 18th. The 1-4 reverse split was announced on Wednesday, August 13th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, August 15th.

ReShape Lifesciences Stock Performance

RSLS stock opened at $3.20 on Thursday. ReShape Lifesciences has a one year low of $1.87 and a one year high of $303.25. The company has a 50 day moving average price of $2.64 and a two-hundred day moving average price of $17.00. The stock has a market capitalization of $7.65 million, a P/E ratio of -0.02 and a beta of 1.16.

ReShape Lifesciences (NASDAQ:RSLS) last announced its quarterly earnings data on Tuesday, May 20th. The medical device company reported $18.98 earnings per share (EPS) for the quarter. ReShape Lifesciences had a negative net margin of 48.26% and a negative return on equity of 251.90%. The company had revenue of $1.11 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of ReShape Lifesciences from a “sell” rating to a “hold” rating in a research note on Saturday, May 24th.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.